WAYNE, PA (February 24, 2016) - LifeScan, BloodVitals device Inc. has introduced the new OneTouch Verio Flex™ blood glucose monitoring system, with ColorSure™ technology - a easy, correct and straightforward-to-use meter that takes the guesswork out of understanding blood sugar check outcomes for folks with diabetes. Its simple coloration vary indicator makes use of color to instantly tell patients when their blood glucose readings are "low," "in vary," or "high" so they can shortly get on with their lives. Nine out of 10 individuals with diabetes agreed that the meter’s color vary indicator helped them simply interpret their blood sugar readings. While it has broad enchantment as a easy, intuitive meter by itself, patients also can use the meter’s built-in Bluetooth® Smart Technology to wirelessly join with the companion OneTouch Reveal® cellular app out there on compatible iOS and Android cell gadgets. "Research shows that ease of use stays an important reason for meter choice by a majority of patients whereas, at the identical time, one third say they can’t make sense of their blood sugar outcomes," mentioned Dr. Jeremy Pettus, BloodVitals device Endocrinologist and Assistant Professor of Medicine on the University of California, San Diego.

"The new OneTouch Verio Flex™ meter is designed to help individuals with diabetes higher understand and manage their blood glucose. The low and high range limits set in the OneTouch Verio Flex™ meter can be customized for each patient based on their healthcare professional’s recommendations. With each take a look at, the easy color range indicator shows whether a result's below limit (blue), inside range (green) or above the limit (red). Nine out of 10 healthcare professionals agreed that realizing when their readings are in or out of range could help patients attain their blood sugar targets and keep in higher management. Currently, there are an estimated 29 million folks with diabetes in the US and many don’t take a look at their blood sugar regularly or as beneficial by their healthcare skilled. Seven out of 10 individuals with diabetes agreed that the OneTouch Verio Flex™ meter with its easy colour vary indicator could encourage them to test as really helpful.

The OneTouch Verio®IQ meter that spots patterns and helps patients perceive how insulin, meals and lifestyle affect their numbers. LifeScan has begun shipping the brand new OneTouch Verio Flex™ system to retailers and it'll quickly be out there nationally wherever diabetes testing supplies are bought with an estimated retail worth of $19.99. OneTouch® is the most beneficial brand by endocrinologists and major care physicians. LifeScan, Inc. is part of the Johnson & Johnson Diabetes Care Companies. With a shared imaginative and prescient of creating a world without limits for individuals with diabetes, the Johnson & Johnson Diabetes Care Companies is a collaboration of Johnson & Johnson companies devoted to diabetes and consists of LifeScan, Inc., a world leader in blood glucose monitoring; Animas Corporation, maker of innovative insulin delivery methods; and Calibra Medical, Inc., developer of a novel 3-day wearable insulin patch pump. Within the US, LifeScan, Inc. is the main maker of blood glucose monitoring systems and its OneTouch® model products are beneficial by extra endocrinologists and primary care physicians than some other model.

Globally, greater than 10 million individuals rely upon OneTouch® model products for easy testing and accurate outcomes to assist them handle their diabetes. This press launch contains "forward-looking statements" as outlined within the Private Securities Litigation Reform Act of 1995 regarding the brand new OneTouch Verio Flex™ blood glucose monitoring system. The reader is cautioned to not rely on these forward-trying statements. These statements are based mostly on current expectations of future occasions. If underlying assumptions show inaccurate or recognized or unknown risks or uncertainties materialize, actual outcomes might range materially from the expectations and projections of LifeScan, Inc. and/or Johnson & Johnson. Risks and uncertainties include, but aren't limited to: uncertainty of business success; challenges to patents; competition, together with technological advances, new products and patents attained by competitors; changes to applicable laws and regulations, together with global well being care reforms; modifications in behavior and spending patterns or financial distress of purchasers of health care products and services; product efficacy or safety considerations resulting in product recalls or regulatory action; manufacturing difficulties and delays; and developments towards well being care price containment.

• 글쓰기

• 수정
• 삭제
• 목록